BR
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis : A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database | Arthritis care & research | 2025 | 14 | 0 | |||
Time to Publication and Time‐Lag Publication Bias for Randomized Trials on Connective Tissue Diseases | ACR open rheumatology | 2023 | 33 | 23 | |||
Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2 | iScience | 2023 | 60 | 36 | |||
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis | Rheumatology | 2022 | 266 | 5 | |||
Extent of and reasons for discontinuation and nonpublication of interventional trials on connective tissue diseases: an observational study | Arthritis care & research | 2022 | 229 | 139 | |||
Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis | Arthritis and Rheumatology | 2021 | 370 | 263 | |||
Interventions for healthcare professionals caring for COVID-19 patients (beyond vaccines): A systematic review | Infection Control and Hospital Epidemiology | 2021 | 234 | 39 | |||
Role of the crosstalk between epithelial and mesenchymal cells in fibrotic disorders focusing on IL-25 within systemic sclerosis | 2020 | 532 | 6 | ||||
Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1 | Frontiers in Immunology | 2018 | 483 | 206 |